caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1184936478

Rashmi Narasimhamurthy

Family PracticeLas Cruces, NMI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Rashmi Narasimhamurthy's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 8 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SEA-MAR COMMUNITY HEALTH CENTER188502
Laboratory Corporation Of America
Clinical Laboratory · Seattle, WA
49122
PROVIDENCE HEALTH & SERVICES WASHINGTON47102
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Seattle, WA
1737
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Seattle, WA
64145
PROVIDENCE HEALTH & SERVICES WASHINGTON54139
SEA-MAR COMMUNITY HEALTH CENTER4371
Laboratory Corporation Of America
Clinical Laboratory · Seattle, WA
2748
Unilab Corporation
Clinical Laboratory · West Hills, CA
2043
SEA-MAR COMMUNITY HEALTH CENTER1825
MULTICARE HEALTH SYSTEM1547
PATHOLOGY ASSOCIATES MEDICAL LABORATORIES LLC1234
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
247
Beneficiaries
—
Total drug cost
$1K
Distinct drugs
11
Brand share
6.1%
Top prescribed drugs
Atorvastatin Calcium48 claims
Amlodipine Besylate39 claims
Losartan Potassium27 claims
Lisinopril25 claims
Omeprazole24 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$99
Payment records
4
By payment type
Food and Beverage$99